Snowball logo
logo
1024

Reyon Pharmaceutical Co Ltd

102460 β€’ KO
β‚©10,080.00β‚©0.00Β  (0%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20212022202320242025TTM
Revenue
Total revenue
142,801.4154,038.8151,071.1148,299.7145,928.6145,221.7
COGS
63,363.672,310.972,172.275,514.3107,697.1111,011.6
Gross Profit
79,437.781,727.978,898.972,785.338,231.634,210
Operating Expenses & Income
Operating Income
3,046.19,322.73,078.4(554.9)(30,687.1)(33,538.4)
Total Operating Expenses
139,755.3144,716.1147,992.8148,854.5176,615.7178,760.1
R&D Expenses
9,725.36,705.38,375.43,317.63,905.74,049.9
Selling General & Admin Expenses
35,532.736,848.131,531.732,638.831,150.430,632
Earnings from Continuing Operations
Interest Expense
(111.2)(122.2)(195.5)(1,253)(13,210.8)(13,428.5)
Interest Income
526.5993.1801.2390225.4220.9
Income Tax Expense
307.5-----
Net Income
Net Income
5,537.37,433.73,583.44,151.2(29,633.1)(40,586.2)
Supplemental
EBIT
1,544.7-----
EBITDA
10,621.711,549.6----
In millions of KRW, except % and values per 1 share